Eleven Biotherapeutics (EBIO) Announces Filing Of Its Annual Report On Form 10-K
4/16/2014 9:21:13 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission.
Help employers find you! Check out all the jobs and post your resume.
comments powered by